.Merck & Co.'s TIGIT course has suffered yet another drawback. Months after shuttering a stage 3 ...
.After a year defined through pipe hairstyles, the variation of its CEO as well as unemployments, Ex...
.Cullinan Rehab was wowed sufficient along with Port BioMed's bispecific immune reactor that it gave...
.In this week's incident of "The Leading Pipe," our team are actually diving into Brutal Biotech's a...
.The confetti is still flying coming from Eli Lilly's celebration celebrating the commendation of Al...
.Invite to today's Chutes & Ladders, our roundup of substantial management hirings, firings and r...
.Observing a poor revealing for Lykos Rehabs' MDMA applicant for post-traumatic stress disorder at a...
.AN2 Therapies is reviewing its own organization in reaction to lackluster midphase data, swearing t...
.Merck & Co. is actually paying out $700 thousand beforehand to challenge Amgen in a blood stream...
.With Gilead Sciences on the verge of an FDA selection for its liver condition medication seladelpar...